Abstract
The human cytomegalovirus (HCMV) open reading frame UL83 encodes a phosphoprotein of 64 to 68kDa (pp65) which is a major constituent of this virion and dense bodies. To determine the importance of the HCMV gene in the virus cycle, we studied HCMV replication in astrocytoma cells stably transfected with a retroviral vector carrying an antisense UL83 cDNA. Reverse transcription-PCR detected antisense RNA in the cytoplasm. The steady-state level of a 4-kb RNA containing coding sequences for pp65 was significantly reduced after infection of antisense cells. Concomitant with this, levels of expression of pp65 and pp71 (UL82) were severely reduced. Extracellular HCMV production was almost completely blocked, irrespective of the multiplicity of infection or the time after infection studied. The block occurred at an early phase, since immediate-early protein synthesis occurred normally, while several late proteins (e.g., pp150 [ppUL32] and assembly protein [UL80]) were absent or strongly inhibited. Normal replication of herpes simplex virus and of a pp65 deletion mutant of HCMV (RVAd65), lacking target sequences of antisense RNA, demonstrated the specificity of the block for wild-type HCMV in the antisense-stabilized cells and indicated that the block was not due to indirect interference with cellular genes. Our results appear to contradict those of Schmolke et al (S. Schmolke, H.F. Kern, P. Drescher, G. Jahn, and B. Plachter, J. Virol. 69:5959-5968, 1995), which show that UL83 is a nonessential gene for HCMV replication in vitro. This contradiction is discussed in light of the fact that the 4-kb mRNA, which codes for pp65 and was targeted in UL83-antisense cell lines, may be a bicistronic mRNA which also codes for pp71 (UL82). Thus, interference of expression from the genes encoding pp65 and pp71 by blocking of this putative bicistronic message leads to severe impairment of viral replication.
Full Text
The Full Text of this article is available as a PDF (1.2 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arbeit R. D., Leary P. L., Levin M. J. Gamma interferon production by combinations of human peripheral blood lymphocytes, monocytes, and cultured macrophages. Infect Immun. 1982 Feb;35(2):383–390. doi: 10.1128/iai.35.2.383-390.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arenzana-Seisdedos F., Virelizier J. L., Fiers W. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol. 1985 Apr;134(4):2444–2448. [PubMed] [Google Scholar]
- Azad R. F., Driver V. B., Tanaka K., Crooke R. M., Anderson K. P. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob Agents Chemother. 1993 Sep;37(9):1945–1954. doi: 10.1128/aac.37.9.1945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bryant L. A., Sinclair J. H. Inhibition of human cytomegalovirus major immediate early gene expression by antisense RNA expression vectors. J Gen Virol. 1993 Sep;74(Pt 9):1965–1967. doi: 10.1099/0022-1317-74-9-1965. [DOI] [PubMed] [Google Scholar]
- Cameron F. H., Jennings P. A. Inhibition of gene expression by a short sense fragment. Nucleic Acids Res. 1991 Feb 11;19(3):469–475. doi: 10.1093/nar/19.3.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cantin E. M., Podsakoff G., Willey D. E., Openshaw H. Antiviral effects of herpes simplex virus specific anti-sense nucleic acids. Adv Exp Med Biol. 1992;312:139–149. doi: 10.1007/978-1-4615-3462-4_14. [DOI] [PubMed] [Google Scholar]
- Depto A. S., Stenberg R. M. Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. J Virol. 1989 Mar;63(3):1232–1238. doi: 10.1128/jvi.63.3.1232-1238.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duclos H., Elfassi E., Michelson S., Arenzana-Seisdedos F., Hazan U., Munier A., Virelizier J. L. Cytomegalovirus infection and trans-activation of HIV-1 and HIV-2 LTRs in human astrocytoma cells. AIDS Res Hum Retroviruses. 1989 Apr;5(2):217–224. doi: 10.1089/aid.1989.5.217. [DOI] [PubMed] [Google Scholar]
- Gibson W. Protein counterparts of human and simian cytomegaloviruses. Virology. 1983 Jul 30;128(2):391–406. doi: 10.1016/0042-6822(83)90265-9. [DOI] [PubMed] [Google Scholar]
- Grefte J. M., van der Gun B. T., Schmolke S., van der Giessen M., van Son W. J., Plachter B., Jahn G., The T. H. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol. 1992 Nov;73(Pt 11):2923–2932. doi: 10.1099/0022-1317-73-11-2923. [DOI] [PubMed] [Google Scholar]
- Gresser I., Bandu M. T., Brouty-boye D., Tovey M. Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature. 1974 Oct 11;251(5475):543–545. doi: 10.1038/251543a0. [DOI] [PubMed] [Google Scholar]
- Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol. 1967 Jun 14;26(2):365–369. doi: 10.1016/0022-2836(67)90307-5. [DOI] [PubMed] [Google Scholar]
- Irmiere A., Gibson W. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology. 1983 Oct 15;130(1):118–133. doi: 10.1016/0042-6822(83)90122-8. [DOI] [PubMed] [Google Scholar]
- Kmetz M. E., Ceruzzi M., Schwartz J. Vmw65 phosphorothioate oligonucleotides inhibit HSV KOS replication and Vmw65 protein synthesis. Antiviral Res. 1991 Sep;16(2):173–184. doi: 10.1016/0166-3542(91)90023-k. [DOI] [PubMed] [Google Scholar]
- Kohler C. P., Kerry J. A., Carter M., Muzithras V. P., Jones T. R., Stenberg R. M. Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome. J Virol. 1994 Oct;68(10):6589–6597. doi: 10.1128/jvi.68.10.6589-6597.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kulka M., Smith C. C., Aurelian L., Fishelevich R., Meade K., Miller P., Ts'o P. O. Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proc Natl Acad Sci U S A. 1989 Sep;86(18):6868–6872. doi: 10.1073/pnas.86.18.6868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landini M. P., Severi B., Furlini G., Badiali De Giorgi L. Human cytomegalovirus structural components: intracellular and intraviral localization of p28 and p65-69 by immunoelectron microscopy. Virus Res. 1987 Jul;8(1):15–23. doi: 10.1016/0168-1702(87)90036-0. [DOI] [PubMed] [Google Scholar]
- Lindenmaier W., Necker A., Krause S., Bonewald R., Collins J. Cloning and characterization of major antigenic determinants of human cytomegalovirus Ad169 seen by the human immune system. Arch Virol. 1990;113(1-2):1–16. doi: 10.1007/BF01318349. [DOI] [PubMed] [Google Scholar]
- Liu B., Stinski M. F. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol. 1992 Jul;66(7):4434–4444. doi: 10.1128/jvi.66.7.4434-4444.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mazeron M. C., Jahn G., Plachter B. Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J Gen Virol. 1992 Oct;73(Pt 10):2699–2703. doi: 10.1099/0022-1317-73-10-2699. [DOI] [PubMed] [Google Scholar]
- Michelson S., Tardy-Panit M., Bârzu O. Properties of a human cytomegalovirus-induced protein kinase. Virology. 1984 Apr 30;134(2):259–268. doi: 10.1016/0042-6822(84)90295-2. [DOI] [PubMed] [Google Scholar]
- Miller A. D., Rosman G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90. [PMC free article] [PubMed] [Google Scholar]
- Pizzorno M. C., O'Hare P., Sha L., LaFemina R. L., Hayward G. S. trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus. J Virol. 1988 Apr;62(4):1167–1179. doi: 10.1128/jvi.62.4.1167-1179.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Revello M. G., Percivalle E., Di Matteo A., Morini F., Gerna G. Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. J Gen Virol. 1992 Feb;73(Pt 2):437–442. doi: 10.1099/0022-1317-73-2-437. [DOI] [PubMed] [Google Scholar]
- Ripalti A., Boccuni M. C., Campanini F., Landini M. P. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J Virol. 1995 Apr;69(4):2047–2057. doi: 10.1128/jvi.69.4.2047-2057.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rüger B., Klages S., Walla B., Albrecht J., Fleckenstein B., Tomlinson P., Barrell B. Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. J Virol. 1987 Feb;61(2):446–453. doi: 10.1128/jvi.61.2.446-453.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scherczinger C. A., Knecht D. A. Co-suppression of Dictyostelium discoideum myosin II heavy-chain gene expression by a sense orientation transcript. Antisense Res Dev. 1993 Summer;3(2):207–217. doi: 10.1089/ard.1993.3.207. [DOI] [PubMed] [Google Scholar]
- Schmolke S., Drescher P., Jahn G., Plachter B. Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport. J Virol. 1995 Feb;69(2):1071–1078. doi: 10.1128/jvi.69.2.1071-1078.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmolke S., Kern H. F., Drescher P., Jahn G., Plachter B. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol. 1995 Oct;69(10):5959–5968. doi: 10.1128/jvi.69.10.5959-5968.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith J. A., Pari G. S. Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication. J Virol. 1995 Mar;69(3):1925–1931. doi: 10.1128/jvi.69.3.1925-1931.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Somogyi T., Michelson S., Masse M. J. Genomic location of a human cytomegalovirus protein with protein kinase activity (PK68). Virology. 1990 Jan;174(1):276–285. doi: 10.1016/0042-6822(90)90075-3. [DOI] [PubMed] [Google Scholar]
- Spaete R. R., Gehrz R. C., Landini M. P. Human cytomegalovirus structural proteins. J Gen Virol. 1994 Dec;75(Pt 12):3287–3308. doi: 10.1099/0022-1317-75-12-3287. [DOI] [PubMed] [Google Scholar]
- Topilko A., Michelson S. Morphological and cytochemical analysis of human cytomegalovirus inoculum: correlation of free particles in inoculum with counterparts in infected cells. Res Virol. 1994 Mar-Apr;145(2):65–73. doi: 10.1016/s0923-2516(07)80008-2. [DOI] [PubMed] [Google Scholar]